首页 正文

Systemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future direction

{{output}}
Combined hepatocellular-cholangiocarcinoma is a rare primary liver malignancy characterized by biphenotypic differentiation and marked biologic heterogeneity. Owing to its low incidence, diagnostic complexity, and lineage plasticity, standardized systemic trea... ...